Juvenescence
corporateWebsite
field
MedicineScience
sub field
BiotechDrug DiscoveryLongevity
approach
ClinicalTranslational
geography
GlobalUnited Kingdom
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
The evidence says Juvenescence secured significant funding for AI-led drug development targeting age-related disease. That makes it a relevant strategic financing or partnership target for OpenDrugs' aging-compound evidence and comparison platform.